Terada T, Hausen M, Mir H, Reed J, Coutinho T
CJC Open. 2025; 7(1):110-119.
PMID: 39872645
PMC: 11763241.
DOI: 10.1016/j.cjco.2024.09.017.
Hamaoka M, Leuenberger U, Gao Z, Aziz F, Kim D, Luck J
Am J Physiol Heart Circ Physiol. 2024; 326(6):H1544-H1549.
PMID: 38700471
PMC: 11380970.
DOI: 10.1152/ajpheart.00225.2024.
Rezvani F, Heider D, Konig H, Herbarth L, Steinisch P, Schuhmann F
Dtsch Arztebl Int. 2024; 121(10):323-330.
PMID: 38269534
PMC: 11413769.
DOI: 10.3238/arztebl.m2024.0008.
Shi H, Yuan X, Wu F, Li X, Fan W, Yang X
Aging (Albany NY). 2024; 16(1):762-778.
PMID: 38198148
PMC: 10817407.
DOI: 10.18632/aging.205417.
Dinc R
Transl Clin Pharmacol. 2024; 31(4):191-201.
PMID: 38196998
PMC: 10772059.
DOI: 10.12793/tcp.2023.31.e18.
Cardiovascular Prognosis in Patients with Peripheral Artery Disease and Approach to Therapy.
Curcio A, Panarello A, Spaccarotella C, Indolfi C
Biomedicines. 2023; 11(12).
PMID: 38137352
PMC: 10740501.
DOI: 10.3390/biomedicines11123131.
Hypertension Management in Peripheral Artery Disease: A Mini Review.
Kharawala A, Nagraj S, Pargaonkar S, Seo J, Kokkinidis D, Altin S
Curr Hypertens Rev. 2023; 20(1):1-9.
PMID: 38083897
DOI: 10.2174/0115734021267004231122061712.
Exercise and Ischemia-Activated Pathways in Limb Muscle Angiogenesis and Vascular Regeneration.
Narkar V
Methodist Debakey Cardiovasc J. 2023; 19(5):58-68.
PMID: 38028974
PMC: 10655757.
DOI: 10.14797/mdcvj.1304.
Target and Cell Therapy for Atherosclerosis and CVD.
Markina Y, Kirichenko T, Tolstik T, Bogatyreva A, Zotova U, Cherednichenko V
Int J Mol Sci. 2023; 24(12).
PMID: 37373454
PMC: 10299192.
DOI: 10.3390/ijms241210308.
Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease.
Bechelli C, Macabrey D, Deglise S, Allagnat F
Int J Mol Sci. 2023; 24(12).
PMID: 37373103
PMC: 10297923.
DOI: 10.3390/ijms24129955.
Activation of the Aryl Hydrocarbon Receptor in Muscle Exacerbates Ischemic Pathology in Chronic Kidney Disease.
Balestrieri N, Palzkill V, Pass C, Tan J, Salyers Z, Moparthy C
Circ Res. 2023; 133(2):158-176.
PMID: 37325935
PMC: 10330629.
DOI: 10.1161/CIRCRESAHA.123.322875.
Coronary Artery Disease in Patients Hospitalized for Peripheral Artery Disease: A Nationwide Analysis of 1.8 Million Patients.
Helmer M, Scheurig-Muenkler C, Brandt V, Tesche C, Bette S, Schwarz F
Diagnostics (Basel). 2023; 13(6).
PMID: 36980471
PMC: 10047185.
DOI: 10.3390/diagnostics13061163.
Development and validation of a prediction model for the prolonged length of stay in Chinese patients with lower extremity atherosclerotic disease: a retrospective study.
Wang X, Yang Y, Zhang J, Zang S
BMJ Open. 2023; 13(2):e069437.
PMID: 36759024
PMC: 9923290.
DOI: 10.1136/bmjopen-2022-069437.
Impact of frailty on disease-specific health status in cardiovascular disease.
Nguyen D, Arnold S
Heart. 2023; 109(13):977-983.
PMID: 36604164
PMC: 10272004.
DOI: 10.1136/heartjnl-2022-321631.
Relationship between serum homocysteine, fibrinogen, lipoprotein-a level, and peripheral arterial disease: a dose-response meta-analysis.
Wang H, Wu P, Jiang D, Zhang H, Zhang J, Zong Y
Eur J Med Res. 2022; 27(1):261.
PMID: 36411481
PMC: 9677707.
DOI: 10.1186/s40001-022-00870-1.
Incidence and Prevalence of Peripheral Arterial Disease in South Korea: Retrospective Analysis of National Claims Data.
Ryu G, Park Y, Kim J, Yang Y, Ko Y, Choi M
JMIR Public Health Surveill. 2022; 8(11):e34908.
PMID: 36399371
PMC: 9719060.
DOI: 10.2196/34908.
Comparison of Aspirin and Rivaroxaban Plus Aspirin in the Management of Stable Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomized Controlled Trials.
Debasu Z, Kedir H, Tadesse T
Int J Gen Med. 2022; 15:7201-7208.
PMID: 36118183
PMC: 9480577.
DOI: 10.2147/IJGM.S383485.
Effects of walking impairment on mental health burden, health risk behavior and quality of life in patients with intermittent claudication: A cross-sectional path analysis.
Rezvani F, Pelt M, Harter M, Dirmaier J
PLoS One. 2022; 17(9):e0273747.
PMID: 36048797
PMC: 9436130.
DOI: 10.1371/journal.pone.0273747.
Nuclear receptors as potential therapeutic targets in peripheral arterial disease and related myopathy.
Kumar A, Narkar V
FEBS J. 2022; 290(19):4596-4613.
PMID: 35942640
PMC: 9908775.
DOI: 10.1111/febs.16593.
Effect of Recombinant Netrin-1 Protein Combined with Peripheral Blood Mesenchymal Stem Cells on Angiogenesis in Rats with Arteriosclerosis Obliterans.
Zeng J, Lu C, Huang H, Huang J
Biomed Res Int. 2022; 2022:3361605.
PMID: 35928912
PMC: 9345694.
DOI: 10.1155/2022/3361605.